Skip to main content
31st International Congress of The Transplantation Society (TTS 2026) | Sydney, Australia | September 20-23, 2026
Innovation through Collaboration

State-of-the-Art Sessions (SOTA/Thematic)

Monday, September 21, 2026
13:30–15:00

Innovating the pathway: Allied health contributions to advancing organ donation and transplantation
  • Driving Excellence in Transplant Care: The Role, Vision and Impact of the TTS Allied Health Committee
    Estephan Arredondo, Barcelona, Spain
  • Extending Organ Viability: The Role of Allied Health in Machine Perfusion Programs
    Joaquim Albiol, Barcelona, Spain
  • Strategies to improve adherence after solid organ transplantation
    Mariel Nöhre, Germany
Bridging Transplantation and Regenerative Medicine: Enhancing Graft Viability and Exploring Stem Cell-Islet Immunotherapies in Diabetes
  • Pancreas Transplantation in Type 2 Diabetes Mellitus
    Peter G. Stock, San Francisco, USA
  • How we can improve Graft viability in pancreas Tx?
    Pablo Uva, Argentina
  • Towards Immunosuppression-Free Transplantation: Stem Cell-Based Approaches and Immune Tolerance
    Hanne Scholz, Oslo/Norway
Minimal Invasive Transplantation
  • Minimally Invasive Thoracic Organ Transplantation
    Albert Jauregui, Barcelona, Spain
  • Minimally Invasive Abdominal Organ Transplantation
    Kwang Woong Lee, Korea Education and Training Strategies to Safely Disseminate Robotic Organ Transplantation Marieke T. de Boer Groningen, Netherlands
  • Future Technological Development in Robotic Organ Transplantation
    Dieter Broering, Saudi Arabia
Donor Evaluation and Optimization: Bridging Safety and Organ Utilization
  • mNGS and Rapid Diagnostics: The Next Frontier in Donor Screening?
    Maricar Malinis, USA
  • HIV-Positive Organ Donation: Evolving Guidelines and Global Perspectives
    Cameron Wolfe, USA
  • MDRO: Cross-Disciplinary Approaches to Donor-Derived Infection Risk Assessment
    Priscilla Rupali, India
  • Donors in the tropics and LMICs: what to consider?
    Siriorn Watacharanan, Thailand
Using Technology to optimize outcomes of Liver Transplantation
  • Normothermic regional perfusion: is ex vivo perfusion still necessary?
    Anji Wall TX, USA
  • What does optimal use of HOPE and NMP look like?
    David Nasralla, UK
  • Ischemia-free organ transplantation
    Guo Zhiyong, Guangzhou, China
  • The future for artificial Intelligence in liver transplant
    Dorry Segev, New York, USA
Precision Immune Engineering in Kidney Transplantation
  • Regulatory T-cell therapy 2.0: CAR-Tregs
    Megan Levings, BC, Canada
Advancing Uterus Transplantation: Global Practices, Innovations, and Program Development
  • Global uterus transplantation activities and outcomes: the ISUTx registry
    Mats Brännström Gothenburg, Sweden
  • Immunosuppression strategies in uterus transplantation
    Stefan Tullius, Boston, USA
  • Robotic surgery in uterus transplantation
    Jean-Marc Ayoubi, Paris, France
  • Setting up a uterus transplantation program
    Rebecca Deans, Sydney, Australia
  • Donor-recipient criteria and availability
    Paige Porrett, Birmingham, USA
Senotherapy in transplantation
  • Cell-type and sex specific aspects of senescence
    Anette Melk, Germany
Bridging systems, scaling access: Asia-pacific leadership in transplantation
  • From Intent to Impact: How to Start and Sustain a Deceased Donation Programme
    Maria Paula Gomez Abu Dhabi
  • Paired Kidney Donation at Scale: Asian Experience Driving Global Dialogue
    Vivek Kute, India
  • From Data to Action: Asian Models of Registry-Driven Transplant Policy Reform
    Curie Ahn, Korea
  • The role of international collaboration in developing transplant programs: A success story from TTS-ILTS paired transplant centers program
    Sergelen Orgoi, Mongolia

Tuesday, September 22, 2026
13:30–15:00

Innovating the pathway: Allied health contributions to advancing organ donation and transplantation
  • Donor intervention studies – ethical and practical challenges
    Dan Harvey, United Kingdom
  • Deceased donor physiological management research
    Gary F. Marklin, United States
  • Biobanks for research
    Claire Gordon, Australia
Targeting immune cell metabolism to control alloimmunity
  • Treg metabolism and the impact of metabolites on their function and disease progression Ling
    Lu Xuzhou, China
  • T cell landscapes following hematopoietic stem cell transplantation
    Simone A Minnie, CA, USA
AI in Transplant Education
  • From concept to classroom: How to start using AI in transplant education?
    Susu Zughaier, Qatar
  • Mixed reality technology in organ transplantation
    Alfred Wei Chieh, KOW, Singapore
Transplanting Against the Antibody Odds
  • Overview of new HLA tools for measuring antibodies and rapid high resolution sequencing
    Sandra Tafulo Portugal
  • Crossing DSA in cardiothoracic transplant: Is necessity the mother of invention?
    Kieran Halloran AB, Canada
  • Immune memory responses: Unmasking the hidden antibody potential
    Gonca Karahan, Netherlands
  • Organ allocation strategies for HLA compatibility
    Phil Clayton, Australia
Redefining Surgical Excellence: Metrics, Equity, and Global Perspectives
  • Driving Quality Improvement Through Global Surgical Registries
    Dimitri A. Raptis, Riyadh, Saudi Arabia
  • Ensuring diversity in the transplant surgery workforce
    Kendra Conzen, CO, USA
  • Fatty liver disease in surgical patient
    Nazia Selzner, ON, Canada
Harnessing the Power of Genetics in Pediatric Transplantation
  • Overview of Genomic Sequencing Techniques
    Katherine Twombley, Florida, USA
  • When and Why to Consider Genetic Testing Pre-Transplant
    Hugh McCarthy, Sydney, Australia
  • Bioethics in Transplant Gene Testing
    Anne Priesz, Sydney, Australia
Biology and beyond: Multiple dimensions of transplantation
  • Addressing gender disparity in access to pediatric kidney transplantation in India
    Kinnari Vala, India/li>
  • Social and cultural conflicts in uterine transplantation
    Limor Danon, Israel
Obesity Management in Transplantation: Current Evidence and Practical Approaches
  • Latest Evidence on GLP-1s in Transplantation
    Babak Orandi, NYU Langone, USA
  • Managing Obesity Without GLP-1s: Alternative Strategies
    Sarah Schmitz, Weill Cornell Medicine, USA
  • Facilitating Weight Loss in Individuals with Frailty and Sarcopenia
    Astrid Ruiz-Margáin, Mexico
Pluripotent stem cells and regenerative medicine: the future of transplantation?
  • Pluripotent stem cells: where are we in building new lungs?
    Rhiannon Werder, Melbourne, Australia
  • Tissue Engineering and Regenerative Medicine: Perspectives on Recent Developments and Directions
    Anthony Weiss, Sydney, Australia
  • Stem Cell derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient
    Shusen Wang, China

Wednesday, September 23, 2026
13:30–15:00

Next-Generation Transplantation
 
Targeted Therapies and Tailored Dosing: The New Era in ABMR Treatment
  • Is there still a role for anti IL-6R in ABMR treatment?
    Roslyn B. Mannon, USA
  • Is anti-CD38 the most promising agent for ABMR?
    Katharina Mayer, Vienna, Austria
  • What does monitoring AUC add compared to C-trough only?
    Teun van Gelder, Leiden, Netherlands
  • Model Informed Precision Dosing
    Anders Asberg, Oslo, Norway
Clinical Xenotransplantation has Arrived!
  • Understanding Optimal genetic modification
    Peter Cowan, Vic, Australia
  • Molecular analysis in clinical xenotransplantation
    armen Lefaucheur, France
  • Clinical xenotransplantation: A new era through the eyes of patients and families
    Macey Levan, NY, USA
Rise of the Machines: Maximizing donor opportunities in Thoracic Transplantation
Normothermic Regional Perfusion or Ex vivo Machine Perfusion for the DCD Heart Donor
  • Pro Normothermic Regional Perfusion
    Ashish S. Shah Nashville Tennesee
  • Pro Ex vivo Machine Perfusion
    Peter Mac Donald, Sydney, Australia
Machine Perfusion versus Immediate Transplantation in DCD Lung Donors
  • Pro Ex vivo Perfusion, Sandra Lindstedt, Sweden
  • Pro Immediate Transplant
    Gregory Snell, Melbourne, Australia
  • Expanding the Donor Pool: Practical Implementation of Normothermic Regional Perfusion for DCD Heart and Lung Recovery
    Irene Bello, Barcelona, Spain
State of VCA- Present and Future
  • Overview of VCA Transplants Hatem Amer Rochester, USA
  • Is VCA Reconstructive Surgery or Transplantation
    Linda Cendales, Durham, NC, USA
  • Challenges and Opportunities for VCA in the Global South
    Subramania Iyer, Kochi, India
  • Standardizing Outcomes in VCA: Are we ready for a SONG or for COVER
    Allison Jaure, Sydney, Australia
Evolving Ethics and Emerging Trends in Transplantation
  • Organ donation after MAID - Global update
    Helen Opdam,
    Australia
  • Social media use in transplantation
    Shaifali Sandal, QC, Canada
  • Ethical Tissue Sourcing for Organoids: Why and How
    Katrina Bramstedt, Switzerland
  • Pediatric prioritization
    Thozama Siyotula, South Africa
  • Retransplantation after nonadherence (adult & children)
    Aaron Wightman, USA
Diversity, Equity, and Inclusion in Gender and Transplantation
  • Invisible Barriers: Gender and Geographic Inequities in Living Donor Recruitment and Support OR Regional and Gender Disparities in abstrascts presented at international transplant congress
    Maggie Ma, Hong Kong SAR, China
  • Unseen and Unequal: Addressing Gender and Financial Disparities in Access to Kidney Transplantation
    MElmi Muller, South Africa
  • Redefining Equity: Women, Access, and Outcomes in Liver Transplantation
    Gomathy Narasimhan, India
Living Organ Donation in 2026: Unified Principles, Organ-Specific Nuances
  • Shared Framework for Living Donor Evaluation: Medical, Psychosocial, and Ethical Core
    Krista Lentine, Saint Louis, MO, USA
  • Surgical Challenges and Functional Outcomes in Living Liver Donation
    Dong-Jin Joo, Korea